Prot #AC-055-404: A randomized, double-blind, placebo-controlled, prospective, multicenter, parallel group study to assess the safety and efficacy of macitentan in patients with portopulmonary hypertension

Project: Research project

Project Details

StatusFinished
Effective start/end date10/8/15 → 1/31/23

Funding

  • PRA Health Sciences ((OE) Prot #AC-055-404 // (OE) Prot #AC-055-404)
  • Actelion Pharmaceuticals Ltd. ((OE) Prot #AC-055-404 // (OE) Prot #AC-055-404)